you can look at cydy/NP compensation here: ht
Post# of 148181
https://simplywall.st/stocks/us/pharmaceutica...management
2 things noted :
#1--Compensation vs Market: Nader's total compensation ($USD9.97M) is above average for companies of similar size in the US market ($USD2.34M).
#2--Compensation vs Earnings: Nader's compensation has increased whilst the company is unprofitable.
NP--"CEO
Nader Pourhassan (57 yo)
8.5yrs --Tenure
US$9,971,254 -- Compensation
Dr. Nader Z. Pourhassan, Ph.D., has been the Chief Executive Officer and President of CytoDyn Inc. since December 17, 2012. Dr. Pourhassan has business, leadership and management experience. Dr. Pourhassan served as an Interim Chief Executive Officer of CytoDyn Inc. since September 10, 2012 and served as its Interim President since September 10, 2012. He served as Managing Director of Business Development at CytoDyn Inc. since June 30, 2011 and served as its Chief Operating Officer from May 2008 to June 30, 2011. For over twenty years, he managed a family-owned export/import and manufacturing business. He has been a Director for CytoDyn Inc. since September 24, 2012. He was an Instructor of Mechanical Engineering at The Center for Advanced Learning, a charter school in Gresham, Oregon from June 2005 through December 2007 and was an Instructor at Mount Hood Community College from 2005 to 2006. Dr. Pourhassan received his Bachelor of Science degree from Utah State University in 1985, his Master of Science Degree from Brigham Young University in 1990 and his Ph.D in Mechanical Engineering from the University of Utah in 1998.